Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF

Discontinued Product

E2-642 has been discontinued.
View all UbcH7/UBE2L3 products.
R&D Systems Recombinant Proteins and Enzymes
1 Image
Product Details
Citations (1)
FAQs
Reviews

Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF Summary

Product Specifications

Purity
>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain
Activity
The Ubiquitin-conjugating (E2) enzyme family receives Ubiquitin from a Ubiquitin-activating (E1) enzyme and subsequently interacts with a Ubiquitin ligase (E3) to conjugate Ubiquitin to substrate proteins. Recombinant Human UbcH7/UBE2L3 Dominant Negative is catalytically inactive and is ideal for use as a negative control. Reaction conditions will need to be optimized for each specific application. We recommend an initial Recombinant Human UbcH7/UBE2L3 Dominant Negative concentration of 0.1-1 μM.
Source
E. coli-derived human UbcH7/UBE2L3 protein
Accession # P68036
Accession #
Predicted Molecular Mass
18 kDa

Product Datasheets

You must select a language.

x

E2-642

Carrier Free

What does CF mean?

CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.

What formulation is right for me?

In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.

E2-642

Formulation Supplied as a solution in HEPES, NaCl, DTT and Glycerol.
Shipping The product is shipped with dry ice or equivalent. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -70 °C as supplied.
  • 3 months, -70 °C under sterile conditions after opening.
Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Background: UbcH7/UBE2L3

Ubiquitin-conjugating Enzyme H7 (UbcH7), also known as Ubiquitin-conjugating Enzyme E2L 3 (UBE2L3), is a member of the Ubiquitin-conjugating (E2) enzyme family (1). It has a predicted molecular weight of approximately 18 kDa. The human UbcH7 protein shares 100% amino acid (aa) sequence identity with the mouse and rat orthologs. UbcH7 has an E2 catalytic core domain that contains an active site cysteine residue and comprises 152 of its 154 aa residues. UbcH7 is catalytically active with HECT and RBR domain-containing families of Ubiquitin ligases (E3s) (2,3). UbcH7 localizes to both the nucleus and cytoplasm in human cells. In mice, its ortholog is expressed in many tissues including brain, muscle, heart, lung, lymph node, spleen, thymus, and testis (4,5). UbcH7 depletion results in an extended S phase and a reduced rate of proliferation, suggesting that it may play a role in the cell cycle (6). In humans, single nucleotide polymorphisms in UbcH7 are associated with systemic lupus erythematosus and Crohn's disease, suggesting that UbcH7 is important for proper immune system function (7,8). This enzyme has a mutation of the active site from cysteine to serine which abolishes the ability of UbcH7 to transfer ubiquitin to an accepting E3 protein. This product is ideal for use as a negative control, competitive control, or to study protein-protein interactions.

References
  1. Nuber, U. et al. (1996) J. Biol. Chem. 271:2795.
  2. Huang, L. et al. (1999) Science 286:1321.
  3. Wenzel, D.M. et al. (2011) Nature 474:105.
  4. Garside, H. et al. (2006) J. Endocrinol. 190:621.
  5. Harbers, K. et al. (1996) Proc. Natl. Acad. Sci. USA 93:12412.
  6. Whitcomb, E.A. et al. (2009) Mol. Biol. Cell 20:1.
  7. Wang, S. et al. (2012) Genes Immun. 13:380.
  8. Fransen, K. et al. (2010) Hum. Mol. Genet. 19:3482.
 
Entrez Gene IDs
7332 (Human); 22195 (Mouse); 363836 (Rat)
Alternate Names
E2-F1; EC 6.3.2.19; L-UBC; UBCE7; UbcH7; UBCH7UbcM4; UbcM4; UBE2L3; Ubiquitin carrier protein L3; ubiquitin-conjugating enzyme E2 L3; Ubiquitin-conjugating enzyme E2-F1; ubiquitin-conjugating enzyme E2L 3; ubiquitin-conjugating enzyme UBCH7; Ubiquitin-protein ligase L3

Citation for Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

1 Citation: Showing 1 - 1

  1. An engineered platform for reconstituting functional multisubunit SCF E3 ligase in vitro
    Authors: H Liu, S Liu, H Yu, X Huang, Y Wang, L Jiang, X Meng, G Liu, M Chen, Y Jing, F Yu, B Wang, J Li
    Molecular plant, 2022-06-24;0(0):.
    Species: Human
    Sample Types: Protein
    Applications: Bioassay

FAQs

No product specific FAQs exist for this product, however you may

View all Proteins and Enzyme FAQs

Reviews for Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF

There are currently no reviews for this product. Be the first to review Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF and earn rewards!

Have you used Recombinant Human UbcH7/UBE2L3 Dominant Negative, CF?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review